 | • レポートコード：MRC2-11QY11230 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はがん遺伝子治療のグローバル市場について調査・分析したレポートです。種類別（腫瘍溶解性ウイルス療法、遺伝子導入、遺伝子誘導免疫療法）市場規模、用途別（病院、診断センター、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別がん遺伝子治療の競争状況、市場シェア ・世界のがん遺伝子治療市場：種類別市場規模 2015年-2020年（腫瘍溶解性ウイルス療法、遺伝子導入、遺伝子誘導免疫療法） ・世界のがん遺伝子治療市場：種類別市場規模予測 2021年-2026年（腫瘍溶解性ウイルス療法、遺伝子導入、遺伝子誘導免疫療法） ・世界のがん遺伝子治療市場：用途別市場規模 2015年-2020年（病院、診断センター、研究所） ・世界のがん遺伝子治療市場：用途別市場規模予測 2021年-2026年（病院、診断センター、研究所） ・北米のがん遺伝子治療市場分析：米国、カナダ ・ヨーロッパのがん遺伝子治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのがん遺伝子治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のがん遺伝子治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのがん遺伝子治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Adaptimmune、Bluebird bio、Celgene、Shanghai Sunway Biotech、Shenzhen SiBiono GeneTech、SynerGene Therapeutics、Altor BioScience、Amgen、Argenx、BioCancell、GlaxoSmithKline、Merck、OncoGenex Pharmaceuticals、Transgene ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
Several unmet medical needs for treatment of cancer have encouraged R&D of cancer gene therapy. Various factors, such as increasing prevalence of cancer, rising government initiatives, increasing funding from various government and non-government organizations, are driving the global cancer gene therapy market. In addition, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment are restraining the growth of global market for cancer gene therapy.
Market Analysis and Insights: Global Cancer Gene Therapy Market
The global Cancer Gene Therapy market size is projected to reach US$ 619.7 million by 2026, from US$ 522 million in 2020, at a CAGR of 17.8%% during 2021-2026.
Global Cancer Gene Therapy Scope and Market Size
Cancer Gene Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Market segment by Type, the product can be split into
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
Market segment by Application, split into
Hospitals
Diagnostics Centers
Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Gene Therapy Revenue
1.4 Market by Type
1.4.1 Global Cancer Gene Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oncolytic Virotherapy
1.4.3 Gene Transfer
1.4.4 Gene-Induced Immunotherapy
1.5 Market by Application
1.5.1 Global Cancer Gene Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostics Centers
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cancer Gene Therapy Market Perspective (2015-2026)
2.2 Global Cancer Gene Therapy Growth Trends by Regions
2.2.1 Cancer Gene Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Gene Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Gene Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cancer Gene Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Gene Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cancer Gene Therapy Players by Market Size
3.1.1 Global Top Cancer Gene Therapy Players by Revenue (2015-2020)
3.1.2 Global Cancer Gene Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Gene Therapy Market Concentration Ratio
3.2.1 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Gene Therapy Revenue in 2019
3.3 Cancer Gene Therapy Key Players Head office and Area Served
3.4 Key Players Cancer Gene Therapy Product Solution and Service
3.5 Date of Enter into Cancer Gene Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Gene Therapy Historic Market Size by Type (2015-2020)
4.2 Global Cancer Gene Therapy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cancer Gene Therapy Market Size by Application (2015-2020)
5.2 Global Cancer Gene Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cancer Gene Therapy Market Size (2015-2020)
6.2 Cancer Gene Therapy Key Players in North America (2019-2020)
6.3 North America Cancer Gene Therapy Market Size by Type (2015-2020)
6.4 North America Cancer Gene Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cancer Gene Therapy Market Size (2015-2020)
7.2 Cancer Gene Therapy Key Players in Europe (2019-2020)
7.3 Europe Cancer Gene Therapy Market Size by Type (2015-2020)
7.4 Europe Cancer Gene Therapy Market Size by Application (2015-2020)
8 China
8.1 China Cancer Gene Therapy Market Size (2015-2020)
8.2 Cancer Gene Therapy Key Players in China (2019-2020)
8.3 China Cancer Gene Therapy Market Size by Type (2015-2020)
8.4 China Cancer Gene Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cancer Gene Therapy Market Size (2015-2020)
9.2 Cancer Gene Therapy Key Players in Japan (2019-2020)
9.3 Japan Cancer Gene Therapy Market Size by Type (2015-2020)
9.4 Japan Cancer Gene Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cancer Gene Therapy Market Size (2015-2020)
10.2 Cancer Gene Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Gene Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Gene Therapy Market Size by Application (2015-2020)
11 India
11.1 India Cancer Gene Therapy Market Size (2015-2020)
11.2 Cancer Gene Therapy Key Players in India (2019-2020)
11.3 India Cancer Gene Therapy Market Size by Type (2015-2020)
11.4 India Cancer Gene Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cancer Gene Therapy Market Size (2015-2020)
12.2 Cancer Gene Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Gene Therapy Market Size by Type (2015-2020)
12.4 Central & South America Cancer Gene Therapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Adaptimmune
13.1.1 Adaptimmune Company Details
13.1.2 Adaptimmune Business Overview
13.1.3 Adaptimmune Cancer Gene Therapy Introduction
13.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2015-2020))
13.1.5 Adaptimmune Recent Development
13.2 Bluebird bio
13.2.1 Bluebird bio Company Details
13.2.2 Bluebird bio Business Overview
13.2.3 Bluebird bio Cancer Gene Therapy Introduction
13.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2015-2020)
13.2.5 Bluebird bio Recent Development
13.3 Celgene
13.3.1 Celgene Company Details
13.3.2 Celgene Business Overview
13.3.3 Celgene Cancer Gene Therapy Introduction
13.3.4 Celgene Revenue in Cancer Gene Therapy Business (2015-2020)
13.3.5 Celgene Recent Development
13.4 Shanghai Sunway Biotech
13.4.1 Shanghai Sunway Biotech Company Details
13.4.2 Shanghai Sunway Biotech Business Overview
13.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Introduction
13.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2015-2020)
13.4.5 Shanghai Sunway Biotech Recent Development
13.5 Shenzhen SiBiono GeneTech
13.5.1 Shenzhen SiBiono GeneTech Company Details
13.5.2 Shenzhen SiBiono GeneTech Business Overview
13.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Introduction
13.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2015-2020)
13.5.5 Shenzhen SiBiono GeneTech Recent Development
13.6 SynerGene Therapeutics
13.6.1 SynerGene Therapeutics Company Details
13.6.2 SynerGene Therapeutics Business Overview
13.6.3 SynerGene Therapeutics Cancer Gene Therapy Introduction
13.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2015-2020)
13.6.5 SynerGene Therapeutics Recent Development
13.7 Altor BioScience
13.7.1 Altor BioScience Company Details
13.7.2 Altor BioScience Business Overview
13.7.3 Altor BioScience Cancer Gene Therapy Introduction
13.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2015-2020)
13.7.5 Altor BioScience Recent Development
13.8 Amgen
13.8.1 Amgen Company Details
13.8.2 Amgen Business Overview
13.8.3 Amgen Cancer Gene Therapy Introduction
13.8.4 Amgen Revenue in Cancer Gene Therapy Business (2015-2020)
13.8.5 Amgen Recent Development
13.9 Argenx
13.9.1 Argenx Company Details
13.9.2 Argenx Business Overview
13.9.3 Argenx Cancer Gene Therapy Introduction
13.9.4 Argenx Revenue in Cancer Gene Therapy Business (2015-2020)
13.9.5 Argenx Recent Development
13.10 BioCancell
13.10.1 BioCancell Company Details
13.10.2 BioCancell Business Overview
13.10.3 BioCancell Cancer Gene Therapy Introduction
13.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2015-2020)
13.10.5 BioCancell Recent Development
13.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Company Details
10.11.2 GlaxoSmithKline Business Overview
10.11.3 GlaxoSmithKline Cancer Gene Therapy Introduction
10.11.4 GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2015-2020)
10.11.5 GlaxoSmithKline Recent Development
13.12 Merck
10.12.1 Merck Company Details
10.12.2 Merck Business Overview
10.12.3 Merck Cancer Gene Therapy Introduction
10.12.4 Merck Revenue in Cancer Gene Therapy Business (2015-2020)
10.12.5 Merck Recent Development
13.13 OncoGenex Pharmaceuticals
10.13.1 OncoGenex Pharmaceuticals Company Details
10.13.2 OncoGenex Pharmaceuticals Business Overview
10.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Introduction
10.13.4 OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2015-2020)
10.13.5 OncoGenex Pharmaceuticals Recent Development
13.14 Transgene
10.14.1 Transgene Company Details
10.14.2 Transgene Business Overview
10.14.3 Transgene Cancer Gene Therapy Introduction
10.14.4 Transgene Revenue in Cancer Gene Therapy Business (2015-2020)
10.14.5 Transgene Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cancer Gene Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Gene Therapy Revenue
Table 3. Ranking of Global Top Cancer Gene Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oncolytic Virotherapy
Table 6. Key Players of Gene Transfer
Table 7. Key Players of Gene-Induced Immunotherapy
Table 8. Global Cancer Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Cancer Gene Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Cancer Gene Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Cancer Gene Therapy Market Share by Regions (2015-2020)
Table 12. Global Cancer Gene Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Cancer Gene Therapy Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Cancer Gene Therapy Market Growth Strategy
Table 18. Main Points Interviewed from Key Cancer Gene Therapy Players
Table 19. Global Cancer Gene Therapy Revenue by Players (2015-2020) (Million US$)
Table 20. Global Cancer Gene Therapy Market Share by Players (2015-2020)
Table 21. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Gene Therapy as of 2019)
Table 22. Global Cancer Gene Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cancer Gene Therapy Product Solution and Service
Table 25. Date of Enter into Cancer Gene Therapy Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cancer Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 28. Global Cancer Gene Therapy Market Size Share by Type (2015-2020)
Table 29. Global Cancer Gene Therapy Revenue Market Share by Type (2021-2026)
Table 30. Global Cancer Gene Therapy Market Size Share by Application (2015-2020)
Table 31. Global Cancer Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 32. Global Cancer Gene Therapy Market Size Share by Application (2021-2026)
Table 33. North America Key Players Cancer Gene Therapy Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Cancer Gene Therapy Market Share (2019-2020)
Table 35. North America Cancer Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 36. North America Cancer Gene Therapy Market Share by Type (2015-2020)
Table 37. North America Cancer Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 38. North America Cancer Gene Therapy Market Share by Application (2015-2020)
Table 39. Europe Key Players Cancer Gene Therapy Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Cancer Gene Therapy Market Share (2019-2020)
Table 41. Europe Cancer Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Cancer Gene Therapy Market Share by Type (2015-2020)
Table 43. Europe Cancer Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Cancer Gene Therapy Market Share by Application (2015-2020)
Table 45. China Key Players Cancer Gene Therapy Revenue (2019-2020) (Million US$)
Table 46. China Key Players Cancer Gene Therapy Market Share (2019-2020)
Table 47. China Cancer Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 48. China Cancer Gene Therapy Market Share by Type (2015-2020)
Table 49. China Cancer Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 50. China Cancer Gene Therapy Market Share by Application (2015-2020)
Table 51. Japan Key Players Cancer Gene Therapy Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Cancer Gene Therapy Market Share (2019-2020)
Table 53. Japan Cancer Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Cancer Gene Therapy Market Share by Type (2015-2020)
Table 55. Japan Cancer Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Cancer Gene Therapy Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Cancer Gene Therapy Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Cancer Gene Therapy Market Share (2019-2020)
Table 59. Southeast Asia Cancer Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Cancer Gene Therapy Market Share by Type (2015-2020)
Table 61. Southeast Asia Cancer Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Cancer Gene Therapy Market Share by Application (2015-2020)
Table 63. India Key Players Cancer Gene Therapy Revenue (2019-2020) (Million US$)
Table 64. India Key Players Cancer Gene Therapy Market Share (2019-2020)
Table 65. India Cancer Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 66. India Cancer Gene Therapy Market Share by Type (2015-2020)
Table 67. India Cancer Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 68. India Cancer Gene Therapy Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Cancer Gene Therapy Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Cancer Gene Therapy Market Share (2019-2020)
Table 71. Central & South America Cancer Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Cancer Gene Therapy Market Share by Type (2015-2020)
Table 73. Central & South America Cancer Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Cancer Gene Therapy Market Share by Application (2015-2020)
Table 75. Adaptimmune Company Details
Table 76. Adaptimmune Business Overview
Table 77. Adaptimmune Product
Table 78. Adaptimmune Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 79. Adaptimmune Recent Development
Table 80. Bluebird bio Company Details
Table 81. Bluebird bio Business Overview
Table 82. Bluebird bio Product
Table 83. Bluebird bio Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 84. Bluebird bio Recent Development
Table 85. Celgene Company Details
Table 86. Celgene Business Overview
Table 87. Celgene Product
Table 88. Celgene Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 89. Celgene Recent Development
Table 90. Shanghai Sunway Biotech Company Details
Table 91. Shanghai Sunway Biotech Business Overview
Table 92. Shanghai Sunway Biotech Product
Table 93. Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 94. Shanghai Sunway Biotech Recent Development
Table 95. Shenzhen SiBiono GeneTech Company Details
Table 96. Shenzhen SiBiono GeneTech Business Overview
Table 97. Shenzhen SiBiono GeneTech Product
Table 98. Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 99. Shenzhen SiBiono GeneTech Recent Development
Table 100. SynerGene Therapeutics Company Details
Table 101. SynerGene Therapeutics Business Overview
Table 102. SynerGene Therapeutics Product
Table 103. SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 104. SynerGene Therapeutics Recent Development
Table 105. Altor BioScience Company Details
Table 106. Altor BioScience Business Overview
Table 107. Altor BioScience Product
Table 108. Altor BioScience Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 109. Altor BioScience Recent Development
Table 110. Amgen Business Overview
Table 111. Amgen Product
Table 112. Amgen Company Details
Table 113. Amgen Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 114. Amgen Recent Development
Table 115. Argenx Company Details
Table 116. Argenx Business Overview
Table 117. Argenx Product
Table 118. Argenx Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 119. Argenx Recent Development
Table 120. BioCancell Company Details
Table 121. BioCancell Business Overview
Table 122. BioCancell Product
Table 123. BioCancell Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 124. BioCancell Recent Development
Table 125. GlaxoSmithKline Company Details
Table 126. GlaxoSmithKline Business Overview
Table 127. GlaxoSmithKline Product
Table 128. GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 129. GlaxoSmithKline Recent Development
Table 130. Merck Company Details
Table 131. Merck Business Overview
Table 132. Merck Product
Table 133. Merck Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 134. Merck Recent Development
Table 135. OncoGenex Pharmaceuticals Company Details
Table 136. OncoGenex Pharmaceuticals Business Overview
Table 137. OncoGenex Pharmaceuticals Product
Table 138. OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 139. OncoGenex Pharmaceuticals Recent Development
Table 140. Transgene Company Details
Table 141. Transgene Business Overview
Table 142. Transgene Product
Table 143. Transgene Revenue in Cancer Gene Therapy Business (2015-2020) (Million US$)
Table 144. Transgene Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Gene Therapy Market Share by Type: 2020 VS 2026
Figure 2. Oncolytic Virotherapy Features
Figure 3. Gene Transfer Features
Figure 4. Gene-Induced Immunotherapy Features
Figure 5. Global Cancer Gene Therapy Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Diagnostics Centers Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Cancer Gene Therapy Report Years Considered
Figure 10. Global Cancer Gene Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Cancer Gene Therapy Market Share by Regions: 2020 VS 2026
Figure 12. Global Cancer Gene Therapy Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Cancer Gene Therapy Market Share by Players in 2019
Figure 15. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Gene Therapy as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2019
Figure 17. North America Cancer Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Cancer Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Cancer Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Cancer Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Cancer Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Cancer Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Cancer Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…- ムコ多糖症（MPS）遺伝子治療の世界市場（～2026年） Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …
- 加齢黄斑変性症（AMD）遺伝子治療の世界市場（～2026年） Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- DNA遺伝子チップの世界市場（～2026年） DNA gene chips or DNA microarrays are tiny chips that are engrafted with DNA molecules. A DNA gene chip size resembles the size of a postage stamp. A DNA microarray consists of a set of microscopic DNA spots attached on a solid surface. Every DNA spot consists of picomoles of a definite DNA sequence…
- 遺伝子発現の世界市場（～2026年） Gene expression is the process by which information from a gene is used in the synthesis of a functional gene product. These products are often proteins, but in non-protein coding genes such as transfer RNA (tRNA) or small nuclear RNA (snRNA) genes, the product is a functional RNA. Market is expecte…